Kerecis to Present Fish-Tissue Graft at APMA 2025
SurgiBind® Tendon Protect designed for preserving motion in surgical tendon management procedures without substantial tissue loss Kerecis, the company pioneering the use of fish-tissue in...
Category : Clinical Research, Pharma & Healthcare Financing
Unite Us & Nomi Health Partner to Streamline Medicaid Payments
New strategic partnership combines Unite Us’ robust billing and reimbursement functionality with Nomi Health’s payment infrastructure to streamline financial flows for critical community services Unite...
LUNGevity Launches Citizen Scientist Program with New Funding
Program builds pipeline of patients and caregivers trained to be directly involved in research LUNGevity Foundation is proud to announce that we been approved for...
Diakonos Doses First Patient in Phase 2 Trial of DOC1021 for GBM
Initial patient dosed at comprehensive cancer center City of Hope as Phase 2 trial prepares to expand to additional premier oncology centers nationwide Diakonos Oncology...
Microcurrent Therapy Effective in Heart Failure: C-MIC II Trial
Berlin Heals and the C-MIC II Investigators today announced the publication of the C-MIC II trial results in the European Journal of Heart Failure. The study, titled “Cardio-microcurrent Device Treatment...
Apnimed Reports Positive Phase 3 Results for Oral OSA Pill AD109
Apnimed, Inc., a pharmaceutical company advancing an industry-leading pipeline of first-in-class oral therapies that address the root causes of obstructive sleep apnea (OSA) and other...
AstraZeneca to Invest $50B in US Medicine Manufacturing
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US Cornerstone of investment is a proposed new...
Protalix BioTherapeutics Names Gilad Mamlok SVP & CFO
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein...
Compugen Doses First Patient in COM701 Global Ovarian Cancer Trial
Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today announced that the first patient...
Revalesio Publishes Phase 2 RESCUE Trial Results on RNS60 for Stroke
Trial met primary endpoints of similar rates of serious adverse events (SAEs) and fewer deaths observed with RNS60 versus placebo Statistically significant reduction in infarct...
J&J Seeks FDA Approval for Icotrokinra to Treat Plaque Psoriasis
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor Filing based on unprecedented data package that met all primary endpoints...
Digostics Launches University Trial for At-Home Type 1 Diabetes Test
Researchers at Yale School of Medicine, funded by Breakthrough T1D, are evaluating GTT@home, a new finger-prick, at-home glucose tolerance test, to monitor early-stage type 1...
PathoCare Accepts Tender Offer at $500M, Plans New Equity Round
PathoCare Holdings, Inc.—the parent company of medical diagnostics innovator PathoCare, LLC (a leader in the Lab-on-a-Chip non-invasive Point of Care diagnostics)—has developed a set of...
Biocytogen, BeOne Sign Antibody Licensing Deal for Drug R&D
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies,...
Cancer Milestones Accelerate as Regulators Shift Focus
Issued on behalf of Oncolytics Biotech Inc. As lawmakers weigh potential cuts to scientific research funding, the outlook for developing cancer cures faces growing uncertainty. The...